FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213020121> ?p ?o ?g. }

• W4213020121 abstract "Hydroxyethyl starch (HES) solutions are used for volume therapy to treat hypovolemia due to acute blood loss and to maintain hemodynamic stability. This study was requested by the European Medicines Agency (EMA) to provide more evidence on the long-term safety and efficacy of HES solutions in the perioperative setting.PHOENICS is a randomized, controlled, double-blind, multi-center, multinational phase IV (IIIb) study with two parallel groups to investigate non-inferiority regarding the safety of a 6% HES 130 solution (Volulyte 6%, Fresenius Kabi, Germany) compared with a crystalloid solution (Ionolyte, Fresenius Kabi, Germany) for infusion in patients with acute blood loss during elective abdominal surgery. A total of 2280 eligible patients (male and female patients willing to participate, with expected blood loss ≥ 500 ml, aged > 40 and ≤ 85 years, and ASA Physical status II-III) are randomly assigned to receive either HES or crystalloid solution for the treatment of hypovolemia due to surgery-induced acute blood loss in hospitals in up to 11 European countries. The dosing of investigational products (IP) is individualized to patients' volume needs and guided by a volume algorithm. Patients are treated with IP for maximally 24 h or until the maximum daily dose of 30 ml/kg body weight is reached. The primary endpoint is the treatment group mean difference in the change from the pre-operative baseline value in cystatin-C-based estimated glomerular filtration rate (eGFR), to the eGFR value calculated from the highest cystatin-C level measured during post-operative days 1-3. Further safety and efficacy parameters include, e.g., combined mortality/major post-operative complications until day 90, renal function, coagulation, inflammation, hemodynamic variables, hospital length of stay, major post-operative complications, and 28-day, 90-day, and 1-year mortality.The study will provide important information on the long-term safety and efficacy of HES 130/0.4 when administered according to the approved European product information. The results will be relevant for volume therapy of surgical patients.EudraCT 2016-002162-30 . ClinicalTrials.gov NCT03278548." @default.
• W4213020121 created "2022-02-24" @default.
• W4213020121 creator A5007121517 @default.
• W4213020121 creator A5007722099 @default.
• W4213020121 creator A5008077890 @default.
• W4213020121 creator A5009588375 @default.
• W4213020121 creator A5010652400 @default.
• W4213020121 creator A5012425190 @default.
• W4213020121 creator A5013698146 @default.
• W4213020121 creator A5013736563 @default.
• W4213020121 creator A5019726220 @default.
• W4213020121 creator A5020376630 @default.
• W4213020121 creator A5027709487 @default.
• W4213020121 creator A5037285192 @default.
• W4213020121 creator A5040649960 @default.
• W4213020121 creator A5050663970 @default.
• W4213020121 creator A5063100825 @default.
• W4213020121 creator A5063467329 @default.
• W4213020121 creator A5073805338 @default.
• W4213020121 creator A5074718034 @default.
• W4213020121 creator A5084523788 @default.
• W4213020121 creator A5084627460 @default.
• W4213020121 creator A5084769002 @default.
• W4213020121 creator A5085402856 @default.
• W4213020121 creator A5085509695 @default.
• W4213020121 creator A5090134389 @default.
• W4213020121 date "2022-02-22" @default.
• W4213020121 modified "2023-10-18" @default.
• W4213020121 title "Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study" @default.
• W4213020121 cites W1503343720 @default.
• W4213020121 cites W1517949191 @default.
• W4213020121 cites W1773643063 @default.
• W4213020121 cites W1914812102 @default.
• W4213020121 cites W191955745 @default.
• W4213020121 cites W1975462325 @default.
• W4213020121 cites W1980970346 @default.
• W4213020121 cites W2010753973 @default.
• W4213020121 cites W2015625030 @default.
• W4213020121 cites W2042042661 @default.
• W4213020121 cites W2064149453 @default.
• W4213020121 cites W2077944368 @default.
• W4213020121 cites W2081755680 @default.
• W4213020121 cites W2095167834 @default.
• W4213020121 cites W2097786723 @default.
• W4213020121 cites W2107286608 @default.
• W4213020121 cites W2113204870 @default.
• W4213020121 cites W2117035897 @default.
• W4213020121 cites W2117953661 @default.
• W4213020121 cites W2118625269 @default.
• W4213020121 cites W2121499426 @default.
• W4213020121 cites W2121876107 @default.
• W4213020121 cites W2128251071 @default.
• W4213020121 cites W2132135347 @default.
• W4213020121 cites W2139937737 @default.
• W4213020121 cites W2141757381 @default.
• W4213020121 cites W2147439788 @default.
• W4213020121 cites W2148706741 @default.
• W4213020121 cites W2150604099 @default.
• W4213020121 cites W2159979844 @default.
• W4213020121 cites W2170312276 @default.
• W4213020121 cites W2170344041 @default.
• W4213020121 cites W2170487286 @default.
• W4213020121 cites W2262478348 @default.
• W4213020121 cites W2321072313 @default.
• W4213020121 cites W2339563374 @default.
• W4213020121 cites W2408512484 @default.
• W4213020121 cites W2581605534 @default.
• W4213020121 cites W2613891180 @default.
• W4213020121 cites W2765764729 @default.
• W4213020121 cites W2921069908 @default.
• W4213020121 cites W3002318022 @default.
• W4213020121 doi "https://doi.org/10.1186/s13063-022-06058-6" @default.
• W4213020121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35193648" @default.
• W4213020121 hasPublicationYear "2022" @default.
• W4213020121 type Work @default.
• W4213020121 citedByCount "5" @default.
• W4213020121 countsByYear W42130201212022 @default.
• W4213020121 countsByYear W42130201212023 @default.
• W4213020121 crossrefType "journal-article" @default.
• W4213020121 hasAuthorship W4213020121A5007121517 @default.
• W4213020121 hasAuthorship W4213020121A5007722099 @default.
• W4213020121 hasAuthorship W4213020121A5008077890 @default.
• W4213020121 hasAuthorship W4213020121A5009588375 @default.
• W4213020121 hasAuthorship W4213020121A5010652400 @default.
• W4213020121 hasAuthorship W4213020121A5012425190 @default.
• W4213020121 hasAuthorship W4213020121A5013698146 @default.
• W4213020121 hasAuthorship W4213020121A5013736563 @default.
• W4213020121 hasAuthorship W4213020121A5019726220 @default.
• W4213020121 hasAuthorship W4213020121A5020376630 @default.
• W4213020121 hasAuthorship W4213020121A5027709487 @default.
• W4213020121 hasAuthorship W4213020121A5037285192 @default.
• W4213020121 hasAuthorship W4213020121A5040649960 @default.
• W4213020121 hasAuthorship W4213020121A5050663970 @default.
• W4213020121 hasAuthorship W4213020121A5063100825 @default.
• W4213020121 hasAuthorship W4213020121A5063467329 @default.
• W4213020121 hasAuthorship W4213020121A5073805338 @default.
• W4213020121 hasAuthorship W4213020121A5074718034 @default.
• W4213020121 hasAuthorship W4213020121A5084523788 @default.
• W4213020121 hasAuthorship W4213020121A5084627460 @default.
• W4213020121 hasAuthorship W4213020121A5084769002 @default.

• next